Skip to main content
Michi Tsuda

Michi Tsuda focuses his practice on operational, regulatory, transactional, and litigation matters in the health care sector. Michi’s clients include hospitals, physician groups, accountable care organizations, management services organizations, private-equity funds, sovereign governments, and health-related joint ventures. He regularly represents private equity clients in the acquisition of health care facilities, with a focus on acute care hospitals, freestanding emergency centers, diagnostic laboratories, and senior care communities, and advises physician practice groups on the organization, sale, and acquisition of physician groups.

Michi also counsels clients on regulatory and compliance matters, including corporate governance, reimbursement, fraud and abuse, and data privacy and security. He routinely drafts compliance program documents, including medical staff bylaws, codes of conduct, and policies and procedures, and represents providers before the Provider Reimbursement Review Board (PRRB), as well as in the Medicare Claims Appeals Process, appealing determinations by Recovery Audit Contractors (RACs), Zone Program Integrity Contractors (ZPICs), and Medicaid Integrity Contractors (MICs).


  • Medicare fraud and abuse (Anti-Kickback, False Claims Act, and Stark laws)
  • Medicare cost report and claims appeals
  • Clinical integration strategies and collaborative care models
  • Mergers and acquisitions, joint ventures and strategic affiliations
  • Medicare and Medicaid enrollment, participation and compliance
  • Domestic and international health care public-private partnerships



  • Representation of HemaCare Corporation, a global leader in the production of human-derived cellular products, in its $380 million cash sale to Charles River Laboratories International, Inc. (NYSE: CRL).
  • Representation of CNS Network and Hassman Research Institute in their merger to form Apex Innovative Sciences, Inc., a national operator of clinical trial sites for central nervous system indications.
  • Lead regulatory counsel for the sale of single specialty and multi-specialty physician groups to private equity-backed firms.
  • Lead regulatory counsel for the sale of ambulatory surgery centers to private equity-backed firms.
  • Lead regulatory counsel for the sale of an adult psychiatric hospital to a private equity-backed firm.
  • Represented a private equity client in the acquisition of a network of freestanding emergency facilities.°
  • Represented private equity clients in the acquisition of acute care hospitals.°
  • Represented private equity clients in the acquisition of diagnostic laboratories.°
  • Represented a strategic buyer in the Chapter 11 case of a healthcare facility.°
  • Appealed over $1 billion of Medicare cost report claims before the Provider Reimbursement Review Board and in subsequent appeals to federal courts and the U.S. Court of Appeals for the District of Columbia Circuit.°
  • Appealed over $50 million of individual claims through the Medicare claims appeals process and in subsequent appeals to administrative law judges.°
  • Advised international sovereign funds and foreign ministries of health in health care public-private partnerships and regulatory infrastructure development.°
  • Represented sole community hospitals with Medicaid supplemental payments and financing issues.°
  • Represented providers under investigation for allegations of fraud and abuse.°
  • Represented group medical practices in the acquisition of ambulatory surgery centers.°
  • Represented financial institutions in assessing investments and loans to health care providers.°
  • Represented investors in the funding and development of acute care hospitals and primary care facilities in Abu Dhabi, Qatar, and Saudi Arabia.°

°The above representations were handled by Mr. Tsuda prior to his joining Greenberg Traurig, LLP.

Sukcesy i wyróżnienia

  • Selected, Super Lawyers magazine, Colorado Super Lawyers Rising Stars,” 2012 and 2017-2020
  • Recognized, Denver Business Journal, “40 under 40,” 2016
  • Selected, American Health Lawyers Association, “Pro Bono Champion,” 2015
  • Member, American Health Lawyers Association
  • Member, Healthcare Financial Management Association
  • Member, American Bar Association
    • Member, Health Law Section
  • Member, Colorado Bar Association
    • Member, Health Law Section
  • Past Board Member, Colorado Asian Pacific American Bar Association


  • J.D., University of Colorado Law School
  • M.B.A., University of Colorado
  • B.A., magna cum laude, Amherst College
Posiadane uprawnienia
  • Colorado
Znajomość języków
  • hiszpański
  • Japanese